Home MannKind Price Target Cut to $4.00 by Analysts at MLV & Co.
 

Keywords :   


MannKind Price Target Cut to $4.00 by Analysts at MLV & Co.

2015-05-18 04:16:11| Biotech - Topix.net

The firm currently has a "hold" rating on the stock. MLV & Co.' s price target would suggest a potential upside of 0.13% from the company's current price.

Tags: co price cut target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11
26.11 GB2 no.022
26.11HL103L SSS
26.115 20cm
26.11 A
26.11fragmentdesign VCD
26.11SwitchSwitch Sea of Stars
26.11[]
More »